Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi
Updated on: August 01,2024
Novel drug application shows improved survival for patients with relapsed and refractory acute myeloid leukemia
byOsaka Metropolitan UniversityEffect of the oral medication venetoclax after allogeneic hematopoietic cell transplantation. Credit: Osaka Metropolitan UniversityRelapsed/refractory acute myeloi
Updated on:August 01,2024
